Drug Type Small molecule drug |
Synonyms Alverine, Bis(gamma-phenylpropyl)ethylamine, Di(phenylpropyl)ethylamine + [7] |
Target |
Mechanism 5-HT1A receptor antagonists(Serotonin 1a (5-HT1a) receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date GB (20 Sep 2018), |
Regulation- |
Molecular FormulaC20H27N |
InChIKeyZPFXAOWNKLFJDN-UHFFFAOYSA-N |
CAS Registry150-59-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07440 | Alverine Citrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diverticulosis, Colonic | GB | 20 Sep 2018 | |
Dysmenorrhea | GB | 20 Sep 2018 | |
Irritable Bowel Syndrome | GB | 20 Sep 2018 |
Phase 4 | 436 | (Meteospasmyl) | zjtycxiqqc(tjrvggjlvt) = hldzagvwme pjhmjaulna (xbneaayjob, mjgxyedced - etqujuxepr) View more | - | 04 Nov 2014 | ||
(Standard of Care) | zjtycxiqqc(tjrvggjlvt) = cnrzzzfbue pjhmjaulna (xbneaayjob, gihevauyzt - kwhojgbxyd) View more |